Lauxera Capital Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
OrganOxorganox.cominJul 2023
OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
BiotechHealthtechMedical DevicesOxford, GB
Prof. Peter Friend(Co-Founder)
Co-investorsAmadeus Capital PartnersBusiness Growth FundHealthQuest CapitalIntuitive VenturesLongwall Venture Partners LLPOxford University Innovation+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.